Download PDF
Radiopraxis 2022; 15(02): E48-E66
DOI: 10.1055/a-1744-2827
CPD-Fortbildung

Diagnostik und Therapie von Gefäßmalformationen

Michael Doppler
,
Wibke Uller
› Further Information
Also available at
CPD
    Permissions and Reprints

Die Gefäßmalformationen zählen zur Erkrankungsgruppe der vaskulären Anomalien. Aufgrund ihres z. T. sehr heterogenen klinischen Erscheinungsbildes werden die vaskulären Malformationen bzw. Anomalien nicht immer korrekt klassifiziert und bezeichnet. Weil sich die Therapien je nach Erkrankung jedoch erheblich unterscheiden, sind eine korrekte Klassifikation und Diagnose essenziell für den Behandlungserfolg.



Publication History

Article published online:
10 June 2022

© 2022. Thieme. All rights reserved.

Georg Thieme Verlag
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • Literatur

  • 1 Mulliken JB, Glowacki J.. Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg 1982; 69: 412-422
    CrossrefPubMedGoogle Scholar
  • 2 Wassef M, Blei F, Adams D. et al. Vascular Anomalies Classification: Recommendations From the International Society for the Study of Vascular Anomalies. Pediatrics 2015; 136: e203-e214
    CrossrefPubMedGoogle Scholar
  • 3 Hammer S, Uller W, Manger F. et al. Time-resolved magnetic resonance angiography (MRA) at 3.0 Tesla for evaluation of hemodynamic characteristics of vascular malformations: description of distinct subgroups. Eur Radiol 2017; 27: 296-305
    CrossrefPubMedGoogle Scholar
  • 4 van Vugt LJ, van der Vleuten CJM, Flucke U. et al. The utility of GLUT1 as a diagnostic marker in cutaneous vascular anomalies: A review of literature and recommendations for daily practice. Pathol Res Pract 2017; 213: 591-597
    CrossrefPubMedGoogle Scholar
  • 5 Wohlgemuth WA, Meyer L, Sadik M.. Gefäßanomalien: Eine interdisziplinäre Herausforderung. Dtsch Arztebl 2017; 114 A-2472/B‑043/C-1997
    Google Scholar
  • 6 Flors L, Leiva-Salinas C, Maged IM. et al. MR imaging of soft-tissue vascular malformations: diagnosis, classification, and therapy follow-up. Radiographics 2011; 31: 1321-1340 discussion 1340-1341
    CrossrefPubMedGoogle Scholar
  • 7 Uller W, Müller-Wille R, Wohlgemuth WA.. Diagnostik und Klassifikation von Gefäßmalformationen. Interventionelle Radiologie Scan 2013; 01: 235-248
    Article in Thieme ConnectGoogle Scholar
  • 8 Ott H.. Symptome – Kapilläre Malformation. Im Internet (Stand: 06.03.2021): https://www.compgefa.de/wissen/symptome-kapillaere-malformation
  • 9 Moukaddam H, Pollak J, Haims AH.. MRI characteristics and classification of peripheral vascular malformations and tumors. Skeletal Radiol 2009; 38: 535-547
    CrossrefPubMedGoogle Scholar
  • 10 Sanlialp I, Karnak I, Tanyel FC. et al. Sclerotherapy for lymphangioma in children. Int J Pediatr Otorhinolaryngol 2003; 67: 795-800
    CrossrefPubMedGoogle Scholar
  • 11 Padwa BL, Hayward PG, Ferraro NF. et al. Cervicofacial lymphatic malformation: clinical course, surgical intervention, and pathogenesis of skeletal hypertrophy. Plast Reconstr Surg 1995; 95: 951-960
    CrossrefPubMedGoogle Scholar
  • 12 Wigle JT, Oliver G.. Prox1 function is required for the development of the murine lymphatic system. Cell 1999; 98: 769-778
    CrossrefPubMedGoogle Scholar
  • 13 Kaipainen A, Korhonen J, Mustonen T. et al. Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc Natl Acad Sci U S A 1995; 92: 3566-3570
    CrossrefPubMedGoogle Scholar
  • 14 Dubois J, Garel L.. Imaging and therapeutic approach of hemangiomas and vascular malformations in the pediatric age group. Pediatr Radiol 1999; 29: 879-893
    CrossrefPubMedGoogle Scholar
  • 15 Smith MC, Zimmerman MB, Burke DK. et al. Efficacy and safety of OK‑432 immunotherapy of lymphatic malformations. Laryngoscope 2009; 119: 107-115
    CrossrefPubMedGoogle Scholar
  • 16 Uller W, Müller-Wille R, Wohlgemuth WA.. Interventionelle Therapie von Gefäßmalformationen. Interventionelle Radiologie Scan 2014; 02: 53-69
    Article in Thieme ConnectGoogle Scholar
  • 17 Shergill A, John P, Amaral JG.. Doxycycline sclerotherapy in children with lymphatic malformations: outcomes, complications and clinical efficacy. Pediatr Radiol 2012; 42: 1080-1088
    CrossrefPubMedGoogle Scholar
  • 18 Yamaki T, Sasaki Y, Hasegawa Y. et al. Percutaneous ultrasound-guided sclerotherapy with polidocanol microfoam for lymphatic malformations. J Vasc Surg Venous Lymphat Disord 2017; 5: 707-714
    CrossrefPubMedGoogle Scholar
  • 19 Yang Y, Sun M, Ma Q. et al. Bleomycin A5 sclerotherapy for cervicofacial lymphatic malformations. J Vasc Surg 2011; 53: 150-155
    CrossrefPubMedGoogle Scholar
  • 20 Puig S, Aref H, Brunelle F.. Double-needle sclerotherapy of lymphangiomas and venous angiomas in children: a simple technique to prevent complications. AJR Am J Roentgenol 2003; 180: 1399-1401
    CrossrefPubMedGoogle Scholar
  • 21 Fayad LM, Hazirolan T, Bluemke D. et al. Vascular malformations in the extremities: emphasis on MR imaging features that guide treatment options. Skeletal Radiol 2006; 35: 127-137
    CrossrefPubMedGoogle Scholar
  • 22 Barbera LC.. Besonderheiten des Krankheitsbildes – Venöse Malformation. Im Internet (Stand: 06.03.2021): https://www.compgefa.de/wissen/besonderheiten-des-krankheitsbildesvenoese-malformation
  • 23 Barbera LC.. Bildgebung – Venöse Malformation. Im Internet (Stand: 06.03.2021): https://www.compgefa.de/wissen/bildgebung-venoese-malformation
  • 24 Mattassi R, Pozzoli W.. Die Marginalvene. Gefässchirurgie 2014; 19: 311-315
    CrossrefGoogle Scholar
  • 25 Ernemann U, Kramer U, Miller S. et al. Current concepts in the classification, diagnosis and treatment of vascular anomalies. Eur J Radiol 2010; 75: 2-11
    CrossrefPubMedGoogle Scholar
  • 26 Upton J, Coombs CJ, Mulliken JB. et al. Vascular malformations of the upper limb: a review of 270 patients. J Hand Surg Am 1999; 24: 1019-1035
    CrossrefPubMedGoogle Scholar
  • 27 Harrison C, Holdstock J, Price B. et al. Endovenous radiofrequency ablation and combined foam sclerotherapy treatment of multiple refluxing perforator veins in a Klippel-Trenaunay syndrome patient. Phlebology 2014; 29: 698-700
    CrossrefPubMedGoogle Scholar
  • 28 King K, Landrigan-Ossar M, Clemens R. et al. The use of endovenous laser treatment in toddlers. J Vasc Interv Radiol 2013; 24: 855-888
    CrossrefPubMedGoogle Scholar
  • 29 Yakes WF, Luethke JM, Parker SH. et al. Ethanol embolization of vascular malformations. Radiographics 1990; 10: 787-796
    CrossrefPubMedGoogle Scholar
  • 30 Teusch VI, Wohlgemuth WA, Hammer S. et al. Ethanol-Gel Sclerotherapy of Venous Malformations: Effectiveness and Safety. AJR Am J Roentgenol 2017; 209: 1390-1395
    CrossrefPubMedGoogle Scholar
  • 31 Gorman J, Zbarsky SJ, Courtemanche RJM. et al. Image guided sclerotherapy for the treatment of venous malformations. CVIR Endovascular 2018; 1: 2
    CrossrefPubMedGoogle Scholar
  • 32 Mimura H, Fujiwara H, Hiraki T. et al. Polidocanol sclerotherapy for painful venous malformations: evaluation of safety and efficacy in pain relief. Eur Radiol 2009; 19: 2474-2480
    CrossrefPubMedGoogle Scholar
  • 33 Donnelly LF, Adams DM, Bisset GS. Vascular malformations and hemangiomas: a practical approach in a multidisciplinary clinic. AJR Am J Roentgenol 2000; 174: 597-608
    CrossrefPubMedGoogle Scholar
  • 34 Uller W.. Symptome – Arteriovenöse Malformation. Im Internet (Stand: 06.03.2021): https://www.compgefa.de/wissen/symptome-arteriovenoese-malformation
  • 35 Enjolras O, Logeart I, Gelbert F. et al. Arteriovenous malformations: a study of 200 cases. Ann Dermatol Venereol 2000; 127: 17-22
    PubMedGoogle Scholar
  • 36 Kohout MP, Hansen M, Pribaz JJ. et al. Arteriovenous malformations of the head and neck: natural history and management. Plast Reconstr Surg 1998; 102: 643-654
    CrossrefPubMedGoogle Scholar
  • 37 Cho SK, Do YS, Shin SW. et al. Arteriovenous malformations of the body and extremities: analysis of therapeutic outcomes and approaches according to a modified angiographic classification. J Endovasc Ther 2006; 13: 527-538
    CrossrefPubMedGoogle Scholar
  • 38 Ranieri M, Wohlgemuth W, Müller-Wille R. et al. Vascular malformations of upper and lower extremity – from radiological interventional therapy to surgical soft tissue reconstruction – an interdisciplinary treatment. Clin Hemorheol Microcirc 2017; 67: 355-372
    CrossrefPubMedGoogle Scholar
  • 39 Lee BB, Do YS, Yakes W. et al. Management of arteriovenous malformations: a multidisciplinary approach. J Vasc Surg 2004; 39: 590-600
    CrossrefPubMedGoogle Scholar
  • 40 Wohlgemuth W, Müller-Wille R, Teusch V. et al. The Retrograde Transvenous Push-Through Method: A Novel Treatment of Peripheral Arteriovenous Malformations with Dominant Venous Outflow. Cardiovasc Intervent Radiol 2015; 38: 623-631
    CrossrefPubMedGoogle Scholar
  • 41 Wohlgemuth WA, Uller W, Muller-Wille R.. Liquid embolic agents-Onyx as problem solver. Radiologe 2013; 53: 223-229
    PubMedGoogle Scholar
  • 42 Sloan RD, Cooley RN.. Congenital pulmonary arteriovenous aneurysm. Am J Roentgenol Radium Ther Nucl Med 1953; 70: 183-210
    PubMedGoogle Scholar
  • 43 White RI. jr. Pulmonary arteriovenous malformations: how do I embolize? Tech Vasc Interv Radiol 2007; 10: 283-290
    PubMedGoogle Scholar
  • 44 Kühnel T.. Besonderheiten des Krankheitsbildes – HHT Morbus Osler. Im Internet (Stand: 06.03.2021): https://www.compgefa.de/wissen/besonderheiten-des-krankheitsbildes-hht-morbus-osler
  • 45 Lawdahl RB, Routh WD, Vitek JJ. et al. Chronic arteriovenous fistulas masquerading as arteriovenous malformations: diagnostic considerations and therapeutic implications. Radiology 1989; 170: 1011-1015
    CrossrefPubMedGoogle Scholar
  • 46 White RI, Pollak JS, Wirth JA.. Pulmonary arteriovenous malformations: diagnosis and transcatheter embolotherapy. J Vasc Interv Radiol 1996; 7: 787-804
    CrossrefPubMedGoogle Scholar